The PROSPER trial: chemotherapy-related endpoints in patients with nonmetastatic castration-resistant prostate cancer treated with enzalutamide

Neal Shore; Fred Saad; Maha Hussain; Karim Fizazi; Per Rathenborg; Eren Demirhan; Katharina Modelska; De Phung; Andrew Krivoshik; Cora N Sternberg

The PROSPER trial: chemotherapy-related endpoints in patients with nonmetastatic castration-resistant prostate cancer treated with enzalutamide

Neal Shore, Fred Saad, Maha Hussain, Karim Fizazi, Per Rathenborg, Eren Demirhan, Katharina Modelska, De Phung, Andrew Krivoshik, Cora N Sternberg

Department of Urology

Original language	English
Publication date	18 May 2018
Publication status	Published - 18 May 2018
Event	AUA 2018 - San Francisco, United States Duration: 18 May 2018 → 21 May 2018

Conference

Conference	AUA 2018
Country/Territory	United States
City	San Francisco
Period	18/05/2018 → 21/05/2018

Cite this

@conference{64012449f2e3421e87a9bf8713c0d1bf,

title = "The PROSPER trial: chemotherapy-related endpoints in patients with nonmetastatic castration-resistant prostate cancer treated with enzalutamide",

author = "Neal Shore and Fred Saad and Maha Hussain and Karim Fizazi and Per Rathenborg and Eren Demirhan and Katharina Modelska and De Phung and Andrew Krivoshik and Sternberg, \{Cora N\}",

year = "2018",

month = may,

day = "18",

language = "English",

note = "AUA 2018 ; Conference date: 18-05-2018 Through 21-05-2018",

}

TY - ABST

T1 - The PROSPER trial: chemotherapy-related endpoints in patients with nonmetastatic castration-resistant prostate cancer treated with enzalutamide

AU - Shore, Neal

AU - Saad, Fred

AU - Hussain, Maha

AU - Fizazi, Karim

AU - Rathenborg, Per

AU - Demirhan, Eren

AU - Modelska, Katharina

AU - Phung, De

AU - Krivoshik, Andrew

AU - Sternberg, Cora N

PY - 2018/5/18

Y1 - 2018/5/18

M3 - Conference abstract for conference

T2 - AUA 2018

Y2 - 18 May 2018 through 21 May 2018

ER -